René Medema
We have been using the complete DNA test for the past two years in the routine care of patients with cancer. The test provides at least as much, and often more, information we can use to treat our patients than regular tests. Moreover, in patients with an unknown primary tumor, it can help us to diagnose the cancer and find a treatment. This test also makes a difference for patients with a sarcoma. Our researchers have scientifically demonstrated this in several studies.
Back to newsMore news
Whole Genome Sequencing for cancer diagnostics clinically validated
Scientific research has demonstrated that Whole Genome Sequencing (WGS) is at least as reliable as routine diagnostic procedures. Clinical Molecular …
Whole Genome Sequencing feasible in clinical practice
Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so important that comprehensive patient reports include precisely that carrier information, if the patient wishes to be informed of it.